| Print
Cumberland Pharmaceuticals (CPIX)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
Address
2525 West End Avenue
Suite 950
Nashville
TN
USA
37203
Telephone
+1 615 2550068
Forecast key dates
| Name | Key Date |
|---|---|
| Cumberland Pharmaceuticals Inc Annual General Meeting for 2026 | 2026-04-22T09:30:00 |
| Cumberland Pharmaceuticals Inc Annual Report for 2025 | 2026-03-06T00:00:00 |
| Cumberland Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2025 | 2026-03-04T16:30:00 |
| Cumberland Pharmaceuticals Inc Fourth Quarter Earnings Results for 2025 | 2026-03-04T00:00:00 |
| Cumberland Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2025 | 2025-11-07T16:30:00 |
| Cumberland Pharmaceuticals Inc Third Quarter Earnings Results for 2025 | 2025-11-07T00:00:00 |
| Cumberland Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2025 | 2025-08-06T16:30:00 |
| Cumberland Pharmaceuticals Inc Second Quarter Earnings Results for 2025 | 2025-08-06T00:00:00 |
| Cumberland Pharmaceuticals Inc First Quarter Earnings Conference Call for 2025 | 2025-05-07T16:30:00 |
| Cumberland Pharmaceuticals Inc First Quarter Earnings Results for 2025 | 2025-05-07T00:00:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.